Does defective nuclear factor-κB-inducing kinase in aly/aly mice prevent bone resorption induced by local injection of lipopolysaccharide?
Taken together, these data show that NIK is important in the bone-destructive components of inflammation and represents a possible therapeutic target.
Despite higher pretreatment NIHSS, patients with LHSs have a 2-fold increased chance of a good outcome 3 months after rt-PA treatment compared with patients with RHSs. This gain can be clinically detected at 24 hours after treatment. These results need to be coupled with neuroimaging and hemodynamic characteristics known to influence stroke outcome.